The Week in Review: Fuan Pharma Completes $214 Million IPO

Chongqing Fuan Pharma raised $214 million in its ChiNext IPO; Zhejiang Hisun Pharma will invest $6 million in a US cancer treatment startup; China Kanghui Holdings bought a 60% stake in Beijing Wei Rui Li Medical Device, a fellow orthopedic device company; Sinopharm Group will acquire a drug distributor in Zhejiang province, Wenling Drug Materials; American Oriental Bio announced a $20 million share buyback; Takeda Pharma of Japan will build R&D and manufacturing facilities at China Medical City in Taizhou; and Novartis plans to increase its China sales force to increase market share. More details…. Stock Symbols: (SHE: 300194) (SHA: 600267) (NYSE: KH) (HK: 1099) (NYSE: AOB) (TSE: 4502) (NYSE: NVS) Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});